Press release
Analytical Standards Market to Reach USD 2.16 Billion by 2030, Driven by Advancements in Drug Development and Regulatory Compliance

United States Pharmacopeial Convention held a key position in the analytical standards market due to its comprehensive portfolio of reference standards. The company has a strong presence across major countries, including India, Brazil, China, Ghana, the P
The global Analytical Standards Market, valued at USD 1.44 billion in 2022, is projected to expand at a robust CAGR of 5.9%, reaching USD 1.53 billion by 2024 and surging to USD 2.16 billion by 2030.
Analytical standards-high-purity substances with defined concentrations-play a pivotal role in laboratory settings, enabling accurate calibration of instruments and validation of analytical methods. These standards serve as reference points for determining the concentration of specific analytes within a sample, ensuring precision and reliability in scientific analysis.
Key Market Drivers
The market's growth is fueled by several critical factors:
* Stringent regulatory frameworks in the pharmaceutical industry
* Rising public and private investments in research and development
* Heightened public concern over food safety and quality
* Expanding use of analytical techniques in proteomics, metabolomics, and clinical diagnostics
Additionally, growing compliance with Good Manufacturing Practice (GMP) standards, ongoing expansion of pharmaceutical and biotechnology industries, and the increasing number of clinical trials are expected to open new avenues for growth.
Download PDF Brochure [https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=8484789&utm_source=abnewswire.com&utm_medium=paidpr&utm_campaign=analyticalstandardsmarket]:
Market Segmentation Highlights
By Technique: The spectroscopy segment is poised for significant growth between 2024 and 2030. This includes a wide range of spectroscopic techniques such as:
* Mass Spectrometry
* Atomic Absorption Spectroscopy
* Infrared (IR) Spectroscopy
* Nuclear Magnetic Resonance (NMR)
* X-ray Fluorescence/Diffraction
* UV-Vis Spectroscopy
The segment's expansion is largely attributed to the increasing application of spectroscopy in drug development research and its versatility across multiple scientific domains.
By Application: The pharmaceutical & life sciences standards segment is expected to dominate the market throughout the forecast period. This is driven by:
* Strict regulatory mandates
* Rising focus on quality assurance
* Growing awareness of analytical standards across key global markets including the US, Europe, China, India, and the Middle East
By Region: Asia Pacific is anticipated to register the highest CAGR during the forecast period. The region-comprising China, India, South Korea, Taiwan, Singapore, and others-is witnessing rapid advancements in the biotech and pharmaceutical sectors. Moreover, regulatory authorities are increasingly enforcing food and drug safety standards, further propelling market demand.
Request Sample Pages: [https://www.marketsandmarkets.com/requestsampleNew.asp?id=8484789&utm_source=abnewswire.com&utm_medium=paidpr&utm_campaign=analyticalstandardsmarket]
Competitive Landscape
The analytical standards market is characterized by a strong presence of global players. Key companies include:
* Merck KGaA (Germany)
* Agilent Technologies, Inc. (US)
* Waters Corporation (US)
* LGC Limited (UK)
* PerkinElmer (US)
* Restek Corporation (US)
* SPEX CertiPrep (US)
* AccuStandard (US)
* Thermo Fisher Scientific, Inc. (US)
* Mallinckrodt (UK)
* United States Pharmacopeial Convention (USP) (US)
* Cayman Chemical (US)
* RICCA Chemical Company (US)
* GFS Chemicals, Inc. (US)
Merck KGaA held a leading position in 2023, supported by a broad product portfolio and operations in over 160 countries. The company continues to invest in both organic and inorganic growth strategies, including recent facility expansions in Nebraska, US, to scale up manufacturing capacity.
United States Pharmacopeial Convention (USP) stands out for its extensive catalog of reference standards and a robust global footprint. With operations across countries such as India, Brazil, China, Ghana, and Switzerland, USP plays a crucial role in the standardization and reliability of analytical procedures worldwide.
[https://www.marketsandmarkets.com/Enquiry_Before_BuyingNew.asp?id=8484789&utm_source=abnewswire.com&utm_medium=paidpr&utm_campaign=analyticalstandardsmarket]
Media Contact
Company Name: MarketsandMarkets Trademark Research Private Ltd.
Contact Person: Mr. Rohan Salgarkar
Email:Send Email [https://www.abnewswire.com/email_contact_us.php?pr=analytical-standards-market-to-reach-usd-216-billion-by-2030-driven-by-advancements-in-drug-development-and-regulatory-compliance]
Phone: 18886006441
Address:1615 South Congress Ave. Suite 103, Delray Beach, FL 33445
City: Florida
State: Florida
Country: United States
Website: https://www.marketsandmarkets.com/Market-Reports/analytical-standards-market-8484789.html
Legal Disclaimer: Information contained on this page is provided by an independent third-party content provider. ABNewswire makes no warranties or responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you are affiliated with this article or have any complaints or copyright issues related to this article and would like it to be removed, please contact retract@swscontact.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Analytical Standards Market to Reach USD 2.16 Billion by 2030, Driven by Advancements in Drug Development and Regulatory Compliance here
News-ID: 4112597 • Views: …
More Releases from ABNewswire

Severe Asthma Clinical Trials 2025: EMA, PDMA, FDA Approvals, Medication, Therap …
Severe Asthma Companies such as Kinaset Therapeutics, Bio-Thera Solutions, CSPC ZhongQi Pharmaceutical Technology, AB Science, GlaxoSmithKline, Oneness Biotech, Biosion, Lanier Biotherapeutics, Kymera Therapeutics, Suzhou Connect Biopharmaceuticals, Upstream Bio, Teva Branded Pharmaceutical Industries, and others.
(Albany, USA) DelveInsight's, "Severe Asthma Pipeline Insight 2025" report provides comprehensive insights about 40+ companies and 50+ pipeline drugs in Severe Asthma pipeline landscape.
The Severe Asthma Pipeline report embraces in-depth commercial and clinical assessment of the pipeline…

Myelodysplastic Syndrome Clinical Trials 2025: EMA, PDMA, FDA Approvals, Medicat …
Myelodysplastic syndrome companies are Novartis, Syros Pharmaceuticals, Curis, Ryvu Therapeutics, Chia Tai Tianqing Pharmaceutical Group, Amgen, Sanofi, Forma Therapeutics, Agios Pharmaceuticals, AbbVie, Daiichi Sankyo Company, Geron Corporation, Astex Pharmaceuticals, Jazz Pharmaceuticals, Maxinovel Pty. Ltd., Mabwell (Shanghai) Bioscience Co., Ltd., BeiGene, Ellipses Pharma, Treadwell Therapeutics, Bellicum Pharmaceuticals, and others.
(Albany, USA) DelveInsight's "Myelodysplastic Syndrome - Pipeline Insight, 2025" offers a detailed analysis of 150+ emerging therapies in development, targeting various MDS subtypes…

Cutaneous T-cell lymphoma Clinical Trials 2025: EMA, PDMA, FDA Approvals, Medica …
Cutaneous T Cell Lymphoma Companies are HyBryte, Resminostat, Mundipharma International, Shanghai Pharmaceuticals Holding, Moleculin Biotech, Inc., BeiGene, Mundipharma Research Limited, Jiangsu Simcere Biologics Co., Ltd, Teva Pharmaceuticals USA, Pfizer, Galderma R&D, Merck Sharp & Dohme LLC, Bio-Path Holdings, Inc., Kymera Therapeutics, Inc., Karyopharm Therapeutics Inc. and others.
(Albany, USA) As per DelveInsight's assessment, globally, Cutaneous T-cell lymphoma pipeline constitutes 25+ key companies continuously working towards developing 30+ Cutaneous T-cell lymphoma treatment…

Ischemic Stroke Clinical Trials 2025: EMA, PDMA, FDA Approvals, Medication, Ther …
Ischemic Stroke companies are Genentech, Supergene, Tasly Pharmaceutical, Pharmazz, GNT Pharma, NoNO, Angde Biotech Pharmaceutical, ZZ Biotech, Bristol-Myers Squibb, Athersys, Bayer Healthcare, NuvOx Pharma, Healios, Acticor Biotech, DiaMedica Therapeutics, Moleac, Biogen, Revalesio Corporation, Shijiazhuang Yiling Pharmaceutical Co. Ltd., and others.
(Albany, United States) As per DelveInsight's assessment, globally, Ischemic Stroke pipeline constitutes 50+ key companies continuously working towards developing 55+ Ischemic Stroke treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of…
More Releases for United
Stock Trading App Market Is Thriving Worldwide: Webull (United States), Interact …
The global Stock Trading App Market is set to experience significant growth from 2025 to 2032, as revealed in the latest in-depth research report published by Market Statistix. This report provides a strategic blend of data-driven insights, risk assessments, and outlook, enabling stakeholders and decision-makers to unlock profitable opportunities and develop long-term investment strategies.
Want to See What's Inside?
Download Free Sample Report Now @ https://www.marketstatistix.com/sample-report/global-stock-trading-app-market
Why This Report Matters:
Whether you're a market…
Sorghum United Announces Rebranding to the Sorghum United Foundation
Following the Launch of their Foundation, Sorghum United Announces Rebranding to the Sorghum United Foundation.
Sorghum United, an international organization dedicated to promoting the benefits of sorghum and millets, proudly announces its rebranding as Sorghum United Foundation, marking a significant step in its mission to combat food insecurity through sustainable solutions. The name change reflects the organization's unwavering commitment to providing access to drought-resistant, sustainable food sources to communities worldwide.
Recognized as…
Automotive Metal Wheel Market Analysis: United States and United Kingdom
The global automotive metal wheel market industry analysis by Fact.MR reveals that the market is expected to be valued at US$ 45.2 Billion in 2022, and is likely to reach US$ 79.91 Billion by 2032, registering a CAGR of 5.9% during the forecast period (2022-2032).
The automotive metal wheel market is a crucial segment of the broader automotive industry, playing a vital role in vehicle safety, performance, and aesthetics. This market…
AI Image Recognition Market Will Hit Big Revenues In Future | Google (United Sta …
According to HTF Market Intelligence, the Global AI Image Recognition market to witness a CAGR of 13.42% during the forecast period (2024-2030). The Latest Released AI Image Recognition Market Research assesses the future growth potential of the AI Image Recognition market and provides information and useful statistics on market structure and size.
This report aims to provide market intelligence and strategic insights to help decision-makers make sound investment decisions and identify…
New study: Walking Canes market forecast to 2025 || Major Players - Hugo Mobilit …
The Walking Canes Market has witnessed continuous growth in the past few years and is projected to grow even further during the forecast period (2019-2025). The assessment provides a 360° view and insights, outlining the key outcomes of the industry. These insights help the business decision-makers to formulate better business plans and make informed decisions for improved profitability. In addition, the study helps venture or private players in understanding the…
Actionable Insights on Digital Transformation in Retail Market 2020-2027 | IBM ( …
Digital Transformation in Retail Market report has recently added by The Research Corporation which helps to make informed business decisions. This research report further identifies the market segmentation along with their sub-types. Various factors are responsible for the market's growth, which are studied in detail in this research report. The report, titled “Global Digital Transformation in Retail Market Research Report 2020,” further explains the major drivers manipulating industry, the possibility…